<DOC>
	<DOCNO>NCT00410514</DOCNO>
	<brief_summary>This study examine safety , tolerability , efficacy mirabegron ( YM178 ) compare placebo .</brief_summary>
	<brief_title>A Study Mirabegron ( YM178 ) Men With Lower Urinary Tract Symptoms ( LUTS ) Bladder Outlet Obstruction ( BOO )</brief_title>
	<detailed_description />
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Urinary Bladder Neck Obstruction</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Men 45 year age older Documented bladder outlet obstruction History urinary retention Symptomatic recurrent urinary tract infection ( UTI )</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Beta-3 Receptor Agonist</keyword>
	<keyword>YM178</keyword>
	<keyword>Men</keyword>
	<keyword>Lower Urinary Tract Symptoms</keyword>
	<keyword>Bladder Outlet Obstruction</keyword>
</DOC>